Tue, Sep 24, 2013 9:53 AM
Investor presentation upon request of the Offeror
Information regarding iInvestor presentation upon request of the Offeror.

Egis Pharmaceuticals PLC (Egis) announces that besides having received today a voluntary
public purchase offer (Offer) from Arts et Techniques du Progrès (Offeror), a wholly owned
subsidiary of Servier Group (Servier) Egis also received from the Offeror and hereby publishes
the attached material regarding an investor presentation.

About Servier


Servier is a privately-held research-led pharmaceutical group, with more than 22,000
employees, including 3,000 in R&D, around the world and is present in more than 140
countries. Organized as a foundation and deeply committed to research, it reinvests a large
portion of its sales in the research and development of innovative medications.

About Egis


Egis, headquartered in Budapest, Hungary, is one of the leading pharmaceutical companies
operating principally in Central Europe and in the CIS (Commonwealth of Independent States)
countries. The company focuses on research, development and commercialization of
pharmaceuticals and active pharmaceutical ingredients for the treatment of cardiovascular,
central nervous system, respiratory and digestive system disorders. The company sells its
products in many countries across the world through business partners and strong subsidiary
companies network.

Related file

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox